GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...
For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
Georgia was one of 18 states with "high" or "very high" levels in wastewater, according to CDC monitoring. Here's what to ...
Has RSV Vaccine Hesitancy Subsided? By Dennis Thompson HealthDay Reporter FRIDAY, Dec. 27, 2024 (HealthDay News) -- More Americans believe in the effectiveness of vaccines developed to protect ...
Positive tests for respiratory illnesses have been steadily climbing for weeks in British Columbia, especially for flu and ...